United States Food and Drug Administration

"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.

Descriptor ID	D014486
MeSH Number(s)	I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
Concept/Terms	United States Food and Drug Administration United States Food and Drug Administration United States Food, Drug Administration USFDA Food and Drug Administration (U.S.) Food and Drug Administration

Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".

Anthropology, Education, Sociology and Social Phenomena [I]
Social Sciences [I01]
Government [I01.409]
Government Agencies [I01.409.418]
United States Government Agencies [I01.409.418.750]
United States Dept. of Health and Human Services [I01.409.418.750.600]
United States Public Health Service [I01.409.418.750.600.650]
United States Food and Drug Administration [I01.409.418.750.600.650.760]
Health Care [N]
Health Care Economics and Organizations [N03]
Organizations [N03.540]
Government [N03.540.348]
Federal Government [N03.540.348.500]
United States Government Agencies [N03.540.348.500.500]
United States Dept. of Health and Human Services [N03.540.348.500.500.600]
United States Public Health Service [N03.540.348.500.500.600.650]
United States Food and Drug Administration [N03.540.348.500.500.600.650.760]

Below are MeSH descriptors whose meaning is related to "United States Food and Drug Administration".

Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.

Bar chart showing 65 publications over 23 distinct years, with a maximum of 9 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1997	1	0	1
2000	2	0	2
2002	0	1	1
2003	0	2	2
2004	0	1	1
2005	0	1	1
2006	0	1	1
2008	0	1	1
2009	1	0	1
2011	1	4	5
2012	1	2	3
2013	1	3	4
2014	3	1	4
2015	0	1	1
2016	2	7	9
2017	1	5	6
2018	2	6	8
2019	0	3	3
2020	1	4	5
2021	0	2	2
2022	0	2	2
2023	0	1	1

Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.

Vandenberg LN, Zoeller RT, Prins GS, Trasande L. Evaluating adverse effects of environmental agents in food: a brief critique of the US FDA's criteria. Environ Health. 2023 04 21; 22(1):38.

View in: PubMed
Donovan SM, Abrams SA, Azad MB, Belfort MB, Bode L, Carlson SE, Dallas DC, Hettinga K, J?rvinen K, Kim JH, Lebrilla CB, McGuire MK, Sela DA, Neu J. Summary of the Joint National Institutes of Health and the Food and Drug Administration Workshop Titled "Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework". J Pediatr. 2023 04; 255:30-41.e1.

View in: PubMed
Davidson BL, Gao G, Berry-Kravis E, Bradbury AM, B?nnemann C, Buxbaum JD, Corcoran GR, Gray SJ, Gray-Edwards H, Kleiman RJ, Shaywitz AJ, Wang D, Zoghbi HY, Flotte TR, Tauscher-Wisniewski S, Tifft CJ, Sahin M. Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders. Mol Ther. 2022 07 06; 30(7):2416-2428.

View in: PubMed
Berg CJ, Barker DC, Meyers C, Weber A, Park AJ, Patterson A, Dorvil S, Fairman RT, Huang J, Sussman S, Livingston MD, Wagener TL, Hayes RB, Pulvers K, Getachew B, Schleicher N, Henriksen L. Exploring the Point-of-Sale Among Vape Shops Across the United States: Audits Integrating a Mystery Shopper Approach. Nicotine Tob Res. 2021 02 16; 23(3):495-504.

View in: PubMed
Berg CJ, Barker DC, Sussman S, Getachew B, Pulvers K, Wagener TL, Hayes RB, Henriksen L. Vape Shop Owners/Managers' Opinions About FDA Regulation of E-Cigarettes. Nicotine Tob Res. 2021 02 16; 23(3):535-542.

View in: PubMed
Alvarez DF, Wolbink G, Cronenberger C, Orazem J, Kay J. Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States? BioDrugs. 2020 Dec; 34(6):723-732.

View in: PubMed
Krishnamoorthy V, Ellis AR, McLean DJ, Stefan MS, Nathanson BH, Cobert J, Lindenauer PK, Brookhart MA, Ohnuma T, Raghunathan K. Bleeding After Musculoskeletal Surgery in Hospitals That Switched From Hydroxyethyl Starch to Albumin Following a Food and Drug Administration Warning. Anesth Analg. 2020 10; 131(4):1193-1200.

View in: PubMed
Tsougranis G, Eldrup-Jorgensen J, Bertges D, Schermerhorn M, Morales P, Williams S, Bloss R, Simons J, Deery SE, Scali S, Roche-Nagle G, Mureebe L, Mell M, Malas M, Pullin B, Stone DH, Malone M, Beck AW, Wang G, Marinac-Dabic D, Sedrakyan A, Goodney PP. The Vascular Implant Surveillance and Interventional Outcomes (VISION) Coordinated Registry Network: An?effort to advance evidence evaluation for vascular?devices. J Vasc Surg. 2020 12; 72(6):2153-2160.

View in: PubMed
Vandenberg LN, Prins GS, Patisaul HB, Zoeller RT. The Use and Misuse of Historical Controls in Regulatory Toxicology: Lessons from the CLARITY-BPA Study. Endocrinology. 2020 05 01; 161(5).

View in: PubMed
Patel SA, Gerber JM. A User's Guide to Novel Therapies for Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2020 05; 20(5):277-288.

View in: PubMed

People

Explore

Similar Concepts

Top Journals